Equity Research firms currently have a positive stance on shares of Psychemedics Corp. (NASDAQ:PMD). The majority of analysts covering the equity have a consensus Strong Buy recommendation on the stock, yielding a score of 1.00. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $32.00 on a short term basis.
At the time of writing, the stock was trading at $19.78. This represents a change from the opening price of -0.15%. In terms of performance, year to date, the stock is 96.15%. The monthly stock performance comes in at -0.80%. For the quarter, shares are performing at 36.80%. Weekly performance analysis shows the equity at 0.15%.
In taking a look at technical levels, shares are trading -1.70% away from the 50 day simple moving average and 35.12% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -10.09% away from it’s 52- week high and 154.90% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Psychemedics Corp.’s RSI stands at 48.53. In looking at volatility levels, the shares saw weekly volatility of 2.29% and 2.80% over the past month.